| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.28 | 1e-11 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.24 | 5e-10 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.25 | 1e-09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.33 | 2e-09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.31 | 3e-09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.33 | 5e-09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.23 | 9e-09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.35 | 2e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-08 |